This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GNRX VanEck Vectors Generic Drugs ETF (GNRX) Price, Holdings, & News Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About VanEck Vectors Generic Drugs ETF (NASDAQ:GNRX) Get GNRX alerts:Sign Up Key Stats Today's Range$22.42▼$22.4250-Day Range$22.42▼$22.4252-Week Range$20.17▼$26.19Volume4 shsAverage Volume1,310 shsMarket Capitalization$3.36 millionAssets Under Management$3.36 millionDividend Yield0.04%Net Expense Ratio0.57%Aggregate RatingN/A ETF Overview Read More VanEck Vectors Generic Drugs ETF ExpensesTypeGNRXHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.56%0.56%0.54%0.53%Other Expenses2.44%0.47%0.56%0.52%0.56%Total Expense2.94%0.75%0.76%0.74%0.73%Fee Waiver-2.37%-0.67%-0.66%-0.50%-0.63%Net Expense0.57%0.60%0.63%0.63%0.60% Receive GNRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VanEck Vectors Generic Drugs ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNRX ETF News HeadlinesAmplify Weight Loss Drug & Treatment ETF (THNR)August 4, 2024 | finance.yahoo.comVanEck Vectors Preferred Securities Ex Financials ETF declares monthly distribution of $0.1422December 4, 2023 | msn.comIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months before it shot up to near double digits and foresaw the oil boom of 2022 say this is a massive and unsettling trend is already impacting your wealth - and could determine the next group of millionaires. (Not AI or crypto). Even The Wall Street Journal calls it a 'New World Order.' Dr. Eifrig warns if you want to be on the winning side of this historic shift, now is the time to move your money. | Stansberry Research (Ad)GDIG ETF Stock Price HistoryNovember 10, 2023 | investing.comVanEck Announces Changes to ETF Product LineApril 18, 2023 | finance.yahoo.comVanEck AEX UCITS ETF (TDT)March 3, 2023 | investing.comSee More Headlines GNRX ETF - Frequently Asked Questions What other stocks do shareholders of VanEck Vectors Generic Drugs ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Vectors Generic Drugs ETF investors own include SLR Investment (SLRC), Saul Centers (BFS), Virtus LifeSci Biotech Products ETF (BBP), Bellevue Healthcare (BBH), Virtus LifeSci Biotech Clinical Trials ETF (BBC), ArrowMark Financial (BANX) and Yamana Gold (AUY). Fund Details IssuerVan Eck Fund NameVanEck Vectors Generic Drugs ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:GNRX Inception Date1/12/2016 Fund ManagerHao-Hung (Peter) Liao, Guo Hua (Jason) Jin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkIndxx Global Generics & New Pharma Index CategorySector FocusHealth Care Development LevelBlended Development RegionGlobal Number of Holdings0 Fund Statistics Assets Under Management$3.36 million Average Daily Volume$591.00 Discount/Premium-0.42% Administrator, Advisor and Custodian AdministratorVan Eck Associates Corporation AdvisorVan Eck Associates Corporation CustodianThe Bank of New York Mellon Corporation DistributorVan Eck Securities Corporation Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerCantor Fitzgerald Miscellaneous Outstanding Shares150,000BetaN/A 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report GNRX Sector ExposureGNRX Industry Exposure This page (NASDAQ:GNRX) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Vectors Generic Drugs ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Vectors Generic Drugs ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNRX Stock Alerts